Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Gastroenterology

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0016-5085(89)90647-1PMID 2546850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man

  2004cited by this paper
• Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects

  2004cited by this paper
• Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.

  1989cited by this paper
• Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.

  1988cited by this paper
• Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?

  1988cited by this paper
• Effect of flumazenil in hepatic encephalopathy.

  1988cited by this paper
• Pharmacokinetics and Clinical Use of Flumazenil (Ro 15-1788)

  1988cited by this paper
• Hepatic encephalopathy and the GABA/benzodiazepine receptor‐chloride ionophore complex: An update

  1988cited by this paper
• Improvement of hepatic encephalopathy treated with flumazenil.

  1988cited by this paper
• IMPROVEMENT OF HEPATIC ENCEPHALOPATHY TREATED WITH FLUMAZENIL

  1988cited by this paper
• Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy

  1988cited by this paper
• Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.

  1987cited by this paper
• Hepatic coma: studies on the target organ.

  1987cited by this paper
• Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788)

  1985cited by this paper
• Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.

  1985cited by this paper
• The Neurobiology of Hepatic Encephalopathy

  1984cited by this paper
• Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.

  1984cited by this paper
• Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.

  1984cited by this paper
• Antagonists of benzodiazepines: functional aspects.

  1983cited by this paper
• Selective antagonists of benzodiazepines

  1981cited by this paper
• Determination of midazolam and its α-hydroxy metabolite in plasma by gas chromatography with electron capture detection

  1981cited by this paper
• The hepatic coma syndromes and lactulose

  1980cited by this paper
• Diseases of the Liver and Biliary System

  1955cited by this paper

• Paradigm shifts in hepatic encephalopathy: Review of recent therapeutic breakthroughs

  2025cites this paper
• Prospecting for para-endogenous anxiolytics in the human microbiome: Some promising pathways.

  2024cites this paper
• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.

  2017cites this paper
• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.

  2017cites this paper
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015cites this paper
• Medication prescribing in liver dysfunction

  2014cites this paper
• Monitoring and managing hepatic disease in anaesthesia.

  2013cites this paper
• GABAergic transmission in hepatic encephalopathy.

  2013cites this paper
• Cómo usar correctamente los fármacos en pacientes con enfermedades hepáticas

  2012cites this paper
• The Role of Natural Benzodiazepines Receptor Ligands in Hepatic Encephalopathy

  2012cites this paper
• Theories of the pathogenesis of hepatic encephalopathy.

  2012cites this paper
• Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der

  2012cites this paper
• Acute Liver Failure, Liver Transplantation, and Extracorporeal Liver Support

  2011cites this paper
• Festschrift for George Fink Neuropsychological aspects of liver disease and its treatment

  2009influential citation
• Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy

  2009cites this paper
• Encefalopatía hepática en perros y gatos

  2009cites this paper
• Neuropsychological Aspects of Liver Disease and its Treatment

  2008influential citation
• The liver and gastrointestinal tract

  2007cites this paper
• Neurological Disorders in the Intensive Care Unit

  2006cites this paper
• Neurological disorders in the intensive care unit.

  2006cites this paper
• Dose Adjustment in Patients with Liver Disease

  2005cites this paper
• Treatment of hepatic encephalopathy - systematic Cochrane reviews of randomised clinical trials

  2005cites this paper
• Flumazenil-Induced Improvement of the Central Dopaminergic System in Rats with Acute Hepatic Failure

  2005cites this paper
• Endozepines in recurrent stupor.

  2005cites this paper
• Pharmacokinetics of flumazenil in fulminant hepatic failure

  2004cites this paper
• Benzodiazepine receptor antagonists for hepatic encephalopathy.

  2004cites this paper
• Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives.

  2004cites this paper
• The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.

  2003cites this paper
• Potential mechanisms of enhanced GABA-mediated inhibitory neurotransmission in liver failure.

  2003cites this paper
• 5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties.

  2003cites this paper
• Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta‐analysis

  2002cites this paper
• Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.

  2001cites this paper
• Naturally occurring benzodiazepines: current status of research and clinical implications

  2000cites this paper
• CHAPTER 39 – LIVER

  2000cites this paper
• Liver: Hepatic Support and the Bioartificial Liver

  2000cites this paper
• Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.

  2000cites this paper
• Pathogenesis of hepatic encephalopathy.

  2000cites this paper
• Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonists.

  1999cites this paper
• PATHOGENESIS OF HEPATIC ENCEPHALOPATHY - A ROLE FOR THE BENZODIAZEPINE RECEPTOR ?

  1999cites this paper
• Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients.

  1999cites this paper
• Drug Treatment of Encephalopathy Associated with Fulminant Liver Failure

  1999cites this paper
• Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An italian multicenter double‐blind, placebo‐controlled, cross‐over study

  1998cites this paper
• [Therapy of acute and chronic hepatic encephalopathy in patients with liver cirrhosis].

  1998cites this paper
• Plasma and CSF Benzodiazepine Receptor Ligand Concentrations in Cirrhotic Patients with Hepatic Encephalopathy: Relationship to Severity of Encephalopathy and to Pharmaceutical Benzodiazepine Intake

  1998cites this paper
• The influence of alcoholism and cirrhosis on benzodiazepine receptor function.

  1998cites this paper
• Cortico-spinal pathways and inhibitory mechanisms in hepatic encephalopathy.

  1997cites this paper
• Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy

  1997cites this paper
• Neurology and the liver

  1997cites this paper
• The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.

  1997cites this paper
• Benzodiazepine-Like Substances and Hepatic Encephalopathy

  1997cites this paper
• New aspects on etiology, biochemistry, and therapy of portal systemic encephalopathy: a critical survey.

  1997cites this paper
• GABAergic inhibition of the pituitary release of adrenocorticotropin and alpha-melanotropin is impaired in dogs with hepatic encephalopathy.

  1996cites this paper
• Metabolic encephalopathies.

  1996cites this paper
• Natural Benzodiazepines and Hepatic Encephalopathy

  1996cites this paper
• Newer Approaches to Therapy of Hepatic Encephalopathy

  1996cites this paper
• Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.

  1996cites this paper
• pathogenesis and treatment of chronic hepatic encephalopathy

  1996cites this paper
• Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.

  1996cites this paper
• Review article: pathogenesis and treatment of chronic hepatic encephalopathy.

  1996cites this paper
• Treatment of hepatic encephalopathy in patients with cirrhosis of the liver.

  1996cites this paper
• Natural benzodiazepines and hepatic encephalopathy.

  1996cites this paper
• Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors.

  1996cites this paper
• [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].

  1996cites this paper
• The role of flumazenil in the critically ill

  1995cites this paper
• Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy.

  1995cites this paper
• The effects of flumazenil in neuropsychiatric disorders.

  1995cites this paper
• Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure

  1995cites this paper
• The benzodiazepine antagonist CGS 8216 prevents hyperammonemia-induced somatostatin receptor reduction in the brain.

  1995cites this paper
• Pharmacology of Gastrointestinal Comorbidity in Alcoholics

  1995cites this paper
• Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients

  1995cites this paper
• General considerations in the management of patients with depressed consciousness and chronic hepatic insufficiency.

  1995cites this paper
• Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy

  1994cites this paper
• The involvement of benzodiazepine receptor ligands in hepatic encephalopathy

  1994cites this paper
• Diagnosis and therapy of hepatic encephalopathy.

  1994cites this paper
• Flumazenil in cirrhotic patients in hepatic coma: A randomized double‐blind placebo‐controlled crossover trial

  1994cites this paper
• Portal-systemic encephalopathy: a disorder of multiple neurotransmitter systems.

  1994cites this paper
• EFFECT OF FLUMAZENIL ON BASAL AND NALOXONE‐STIMULATED ACTH AND CORTISOL RELEASE IN HUMANS

  1994cites this paper
• Flumazenil as a diagnostic tool in the differential diagnosis of coma in a critically ill patient

  1994cites this paper
• Endotoxin and tumor necrosis factor-alpha in the pathogenesis of hepatic encephalopathy.

  1994cites this paper
• Benzodiazepine‐receptor ligands and hepatic encephalopathy: A causal relationship?

  1994cites this paper
• The GABA hypothesis--state of the art.

  1994cites this paper
• Idiopathic recurring stupor

  1994cites this paper
• Neuropharmacologic modulation of hepatic encephalopathy: experimental and clinical data.

  1994cites this paper
• [Hepatic coma].

  1994cites this paper
• Rolling review: the treatment of major complications of cirrhosis.

  1994cites this paper
• The treatment of major complications of cirrhosis

  1994cites this paper
• Presence of Endogenous Benzodiazepine-Like Compound in Patients with Anoxic Encephalopathy

  1994cites this paper
• Temporary abolition of seizure activity by flumazenil in a case of valproate-induced non-convulsive status epilepticus.

  1993cites this paper
• Clinical manifestations and therapy of hepatic encephalopathy.

  1993cites this paper
• Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.

  1993cites this paper
• Benzodiazepine-receptor antagonists and hepatic encephalopathy: where do we stand?

  1993cites this paper
• Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy

  1993cites this paper
• [What is guaranteed in the therapy of hepatic encephalopathy?].

  1993cites this paper
• Hepatische Enzephalopathie: Pathophysiologie und Behandlungsmöglichkeiten

  1993cites this paper
• Hepatic encephalopathy in rats with thioacetamide-induced acute liver failure is not mediated by endogenous benzodiazepines.

  1993cites this paper
• Do benzodiazepine ligands contribute to hepatic encephalopathy?

  1993cites this paper
• Increased benzodiazepine‐like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide‐treated rat

  1993cites this paper
• Management of end-stage liver disease.

  1993cites this paper
• Drug Information Analysis Service

  1993cites this paper
• Flumazenil in the treatment of hepatic encephalopathy.

  1993cites this paper